GlassScriptPhysician profile
Timothy Mcshurley
NPI 1295984748
$6,008.86
in general payments reported to CMS, 2019-2025
40 companies · $792 in 2025
The $792 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $502 · 2020: $1,600 · 2021: $611 · 2022: $703 · 2023: $561 · 2024: $1,240 · 2025: $792.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,594.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,593.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,405.23 | 2020 | |
| Abiomed | $595.15 | 2019-2025 | Impella |
| Merck Sharp & Dohme LLC | $505.14 | 2021-2025 | Verquvo, Capvaxive |
| E.R. Squibb & Sons, L.L.C. | $428.34 | 2020-2025 | Eliquis, Camzyos |
| Amgen INC. | $308.96 | 2020-2025 | Repatha, Repatha |
| Abbott Laboratories | $249.67 | 2020-2025 | Xience Skypoint, Mitraclip, Esprit |
| Pfizer INC. | $232.71 | 2021-2025 | |
| Medtronic, INC. | $209.39 | 2023-2024 | Crome Dr Mri Surescan, Micra, Corevalve Evolut R |
| Novartis Pharmaceuticals Corporation | $189.07 | 2021-2025 | |
| Shockwave Medical, INC | $171.94 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $157.17 | 2019-2024 | Watchman Flx, Watchman Access System |
| Chiesi USA, INC. | $147.87 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $144.85 | 2019-2025 | Farxiga |
| Janssen Pharmaceuticals, INC | $114.14 | 2022-2023 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $90.59 | 2020-2025 | Lifevest |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Mcshurley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.